scispace - formally typeset
P

Patrick Schaerli

Researcher at University of Bern

Publications -  22
Citations -  5416

Patrick Schaerli is an academic researcher from University of Bern. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 18, co-authored 22 publications receiving 5161 citations. Previous affiliations of Patrick Schaerli include Brigham and Women's Hospital & Harvard University.

Papers
More filters
Journal ArticleDOI

Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation

TL;DR: Different patterns of chemokine receptors in immature and mature DC are consistent with “inflammatory” and “primary response” phases of DC function.
Journal ArticleDOI

Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function

TL;DR: These properties portray CXCR5+ T cells as a distinct memory T cell subset with B cell helper function, designated here as follicular B helper T cells (TFH).
Journal ArticleDOI

Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues

TL;DR: It is shown that mouse thoracic duct lymph contains HSPCs that possess short- and long-term multilineage reconstitution capacity and can foster the local production of tissue-resident innate immune cells under both steady-state conditions and in response to inflammatory signals.
Journal ArticleDOI

Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus.

TL;DR: It is shown that circulating DCs were recruited to the thymic medulla through a three-step adhesion cascade involving P-selectin, interactions of the integrin VLA-4 with its ligand VCAM-1, and pertussis toxin–sensitive chemoattractant signaling.
Journal ArticleDOI

Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues

TL;DR: It is proposed that the tissue distribution of T(PS) cells is determined by a distinct set of chemokines and corresponding receptors that differs from those operating in secondary lymphoid tissues and inflammatory sites.